ImmuneAge Bio

ImmuneAge Bio

ImmuneAge Bio is dedicated to rejuvenating the immune system by targeting bone marrow stem cells and other immune cells. Our mission is to extend human healthspan by developing innovative therapies that restore and enhance immune function, addressing both aging and immune-related conditions.

Leader

ImmuneAge Bio

Sebastian Brunemeier, CEO and founder of ImmuneAge Bio, is a seasoned biotech entrepreneur with a strong focus on longevity research. With a background in launching successful biotech companies like Cambrian Biopharma and Samsara Therapeutics, Sebastian has now turned his attention to revolutionizing immune system rejuvenation through targeted interventions in stem cells.

About

ImmuneAge Bio is pioneering the rejuvenation of the immune system by focusing on bone marrow stem cells and T-cells. Our platform identifies new molecules that expand and rejuvenate hematopoietic stem cells and mesenchymal stem cells. These cells are then re-infused into the body, offering a non-invasive outpatient procedure aimed at enhancing immune function and combating aging.

Core Projects

No items found.

Milestones

No items found.

Collaborative Opportunities

Is your organization ready to join the fight against aging?

Apply to become a Certified Vitalist Organization and align with others dedicated to this mission

CERTIFICATION APPLICATION